Drug details

Mepron (atovaquone)

type of Antimalarials

Mepron (atovaquone) is an antiprotozoal agent indicated for the prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX) and is indicated for the acute oral treatment of mild-to-moderate PCP in patients who are intolerant to TMP-SMX.

The drug is often used to treat Pneumonia .

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• diarrhea,
• weakness,
• constipation,
• skin rash,
• stomach pain or upset,
• muscle pain,
• sleep problems (insomnia).
• sweating, or

The following drugs are related to Mepron, either as a replacement or used together:

• Principen (ampicillin)
• Artesunate (artesunate)
• Evotaz (atazanavir and cobicistat tablets for oral administration)
• Suprax (cefixime)
• Cefzil (cefprozil)
• Edurant (rilpivirine tablets)
• Fuzeon (enfuvirtide)
• Intelence (etravirine tablets)
• Lexiva (fosamprenavir calcium)
• Selzentry (maraviroc)
• Viread (tenofovir disoproxil fumarate)
• Valcyte (valganciclovir hcl)

The following supplements are related to Mepron, and may be used together with the drug:

• Alpha-Linolenic Acid (s.)